Di Yang , Lingwei Huang , Jiamin Wang , Huihao Wu , Zhenbin Liu , Ayimuguli Abudureyimu , Zilin Qiao
{"title":"MDCK细胞系的肿瘤发生机制及应用策略综述","authors":"Di Yang , Lingwei Huang , Jiamin Wang , Huihao Wu , Zhenbin Liu , Ayimuguli Abudureyimu , Zilin Qiao","doi":"10.1016/j.biologicals.2023.101699","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>Influenza is an acute respiratory infectious disease<span> caused by influenza virus that seriously endangers people's health. Influenza vaccination is the most effective means to prevent influenza </span></span>virus infection and its serious complications. </span>MDCK cells<span><span> are considered to be superior to chicken embryos for the production of influenza vaccines, but the </span>tumorigenicity of cells is a concern over the theoretical possibility of the risk of adverse events. The theoretical risks need to be adequately addressed if public confidence in programs of immunization are to be maintained. In this paper, studies of the tumorigenic potential of cell lines, with MDCK cells as an example, published since 2010 are reviewed. The mechanism of tumorigenicity of MDCK cells is discussed with reference to </span></span>cell heterogeneity<span> and epithelial to mesenchymal transition (EMT). Understanding the mechanism of the acquisition of a tumorigenic phenotype by MDCK cells might assist in estimating potential risks associated with using tumorigenic cell substrates for vaccine production.</span></p></div>","PeriodicalId":55369,"journal":{"name":"Biologicals","volume":"83 ","pages":"Article 101699"},"PeriodicalIF":1.5000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tumorigenesis mechanism and application strategy of the MDCK cell line: A systematic review\",\"authors\":\"Di Yang , Lingwei Huang , Jiamin Wang , Huihao Wu , Zhenbin Liu , Ayimuguli Abudureyimu , Zilin Qiao\",\"doi\":\"10.1016/j.biologicals.2023.101699\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span><span>Influenza is an acute respiratory infectious disease<span> caused by influenza virus that seriously endangers people's health. Influenza vaccination is the most effective means to prevent influenza </span></span>virus infection and its serious complications. </span>MDCK cells<span><span> are considered to be superior to chicken embryos for the production of influenza vaccines, but the </span>tumorigenicity of cells is a concern over the theoretical possibility of the risk of adverse events. The theoretical risks need to be adequately addressed if public confidence in programs of immunization are to be maintained. In this paper, studies of the tumorigenic potential of cell lines, with MDCK cells as an example, published since 2010 are reviewed. The mechanism of tumorigenicity of MDCK cells is discussed with reference to </span></span>cell heterogeneity<span> and epithelial to mesenchymal transition (EMT). Understanding the mechanism of the acquisition of a tumorigenic phenotype by MDCK cells might assist in estimating potential risks associated with using tumorigenic cell substrates for vaccine production.</span></p></div>\",\"PeriodicalId\":55369,\"journal\":{\"name\":\"Biologicals\",\"volume\":\"83 \",\"pages\":\"Article 101699\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biologicals\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1045105623000374\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biologicals","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1045105623000374","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
Tumorigenesis mechanism and application strategy of the MDCK cell line: A systematic review
Influenza is an acute respiratory infectious disease caused by influenza virus that seriously endangers people's health. Influenza vaccination is the most effective means to prevent influenza virus infection and its serious complications. MDCK cells are considered to be superior to chicken embryos for the production of influenza vaccines, but the tumorigenicity of cells is a concern over the theoretical possibility of the risk of adverse events. The theoretical risks need to be adequately addressed if public confidence in programs of immunization are to be maintained. In this paper, studies of the tumorigenic potential of cell lines, with MDCK cells as an example, published since 2010 are reviewed. The mechanism of tumorigenicity of MDCK cells is discussed with reference to cell heterogeneity and epithelial to mesenchymal transition (EMT). Understanding the mechanism of the acquisition of a tumorigenic phenotype by MDCK cells might assist in estimating potential risks associated with using tumorigenic cell substrates for vaccine production.
期刊介绍:
Biologicals provides a modern and multidisciplinary international forum for news, debate, and original research on all aspects of biologicals used in human and veterinary medicine. The journal publishes original papers, reviews, and letters relevant to the development, production, quality control, and standardization of biological derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern.Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.